Scopus Asset Management’s Corteva CTVA Stock Holding History

Scopus Asset Management’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-200,000	Closed	-$5.91M	–	136
2019 Q2	$5.91M	Buy	+200,000	New	+$5.38M	0.17%	129

Other funds holding CTVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Scopus Asset Management's CTVA Position: Q2 2026 in Review

Scopus Asset Management sold out of Corteva (CTVA) in Q2 2026, closing a stake of 125,000 shares — an estimated $10.5M sold.

Scopus Asset Management first reported a position in CTVA in Q2 2023 and held it in 4 quarters. The position peaked at $13.4M in Q4 2025. 1,491 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

Scopus Asset Management reported no remaining Corteva position as of Q2 2026 after selling out during the quarter.
Scopus Asset Management sold 125,000 Corteva shares in Q2 2026, an estimated $10.5M.
Scopus Asset Management first reported a position in Corteva in Q2 2023 and held it in 4 quarters.
Scopus Asset Management's Corteva position peaked at $13.4M in Q4 2025.
1,491 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Scopus Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.